Why you should stop scrolling in the bathroom and the unsavory truth about your phone.

Published Date: 26 Apr 2023

More than 90% of people in the world own or use a mobile phone, and many of us couldn't live without them. We carry them everywhere we go, use them in bed and the bathroom, and for many people, they are the first thing they see in the morning.

Read Full News

Latest News

USDA Cyclospora Research Projects Shelved Amid Funding Cuts and Relocations, Politico Reports

The Trump administration is shuttering two of the three U.S. Department of Agriculture research projects studying cyclospora, ⁠a foodborne parasite that has sickened...

Measles Cases in Pennsylvania Rise to 460 Amid Ongoing Outbreak

Pennsylvania's health department said on Friday the confirmed number of cases linked to a measles ⁠outbreak has reached 460 this year, an increase of 36 over its update two...

More Than 6,000 People Infected With Ebola in Congo, Government Figures Show

The number of confirmed Ebola ⁠cases in the Democratic Republic of Congo has ⁠passed the 6,000 mark, government data ⁠showed on Monday.

US Widens Lettuce-related Cyclosporiasis Probe to 20 States

U.S. health authorities have widened their probe into a cyclosporiasis outbreak tied to iceberg lettuce ⁠from central Mexico after detecting cases in three additional...

US FDA Approves Updated COVID Vaccines for 2026-27 Season

The U.S. Food and Drug Administration approved Moderna, Novavax-Sanofi ⁠and Pfizer-BioNTech's updated COVID vaccines, the companies said on Thursday, ⁠after an advisory...

HIV Resistance Assay Offers Quick, Low-Cost Results for RTs

The assay’s significant limitation is its inability to assess drug resistance for integrase inhibitors, including dolutegravir, a first-line drug with growing resistance.

Todays Updates

Low Awareness of How to Spot Rare Breast Cancer Identified

Researchers survey US adults to assess their knowledge of inflammatory breast cancer.

Remote CBT for Insomnia Improves Symptoms During Chemo

A new randomized trial strengthens the case for managing cancer-related insomnia with cognitive-behavioral therapy.

Long-Acting Interferon Therapy Approved for ET

Ropeginterferon alfa-2b is designed to provide durable disease control.

Todays Updates

Low Awareness of How to Spot Rare Breast Cancer Identified

Researchers survey US adults to assess their knowledge of inflammatory breast cancer.

Remote CBT for Insomnia Improves Symptoms During Chemo

A new randomized trial strengthens the case for managing cancer-related insomnia with cognitive-behavioral therapy.

Long-Acting Interferon Therapy Approved for ET

Ropeginterferon alfa-2b is designed to provide durable disease control.

Latest News

The Trump administration is shuttering two of the three U.S. Department of Agriculture research projects studying cyclospora, ⁠a foodborne parasite that has sickened...

Pennsylvania's health department said on Friday the confirmed number of cases linked to a measles ⁠outbreak has reached 460 this year, an increase of 36 over its update two...

The number of confirmed Ebola ⁠cases in the Democratic Republic of Congo has ⁠passed the 6,000 mark, government data ⁠showed on Monday.

U.S. health authorities have widened their probe into a cyclosporiasis outbreak tied to iceberg lettuce ⁠from central Mexico after detecting cases in three additional...

The U.S. Food and Drug Administration approved Moderna, Novavax-Sanofi ⁠and Pfizer-BioNTech's updated COVID vaccines, the companies said on Thursday, ⁠after an advisory...

The assay’s significant limitation is its inability to assess drug resistance for integrase inhibitors, including dolutegravir, a first-line drug with growing resistance.

News All Time

STI Rates Fall Two Thirds After Clinic Initiation of DoxyPEP

Real-world data revealed a high level of effectiveness on par with clinical trial data even among a high-risk population.

Dolutegravir-Lamivudine Sustains HIV Suppression

A French observational study shows sustained virologic control with minimal resistance emergence and a favorable safety profile in routine clinical practice.

PEPFAR Disruptions Cut HIV Services in 2025

In addition to projections of over a half million potential new HIV infections from persistent disruption, US global health security may be threatened by downstream effects of the cuts, expert says.

Dengue Cases Surge in Malaysia's Klang Valley, Says Health Ministry

Dengue fever cases have surged in the Malaysian capital Kuala Lumpur and the surrounding Klang Valley area, the ⁠country's health ministry said on Friday, warning of a high...

Michigan Reports About 3% Weekly Rise in Cyclosporiasis Cases as Outbreak Begins to Slow

Michigan's health department on Thursday reported 14,277 cases linked to a cyclosporiasis outbreak, up 368 or about 3% from a week earlier, with the slower ⁠pace of increase...

Congo Set to Receive 70,000 Ervebo Vaccines to Contain Ebola Outbreak, WHO Says

The Democratic Republic of Congo has been allocated 70,000 doses of Merck's Ervebo vaccine for Ebola, the World Health ⁠Organization said on Thursday, as the country...

Lenacapavir PrEP: No New HIV infections & High Satisfaction

Participants in the PURPOSE 1 trial particularly appreciated the convenience of not needing a daily pill and the confidence of feeling protected from HIV long-term.

Ebola Cases in Congo Exceed 5,000, Government Data Shows

The number of confirmed Ebola cases in the Democratic Republic ⁠of Congo now exceeds 5,000, government data showed late on Tuesday, as ⁠health officials warn that response...

Kids With Complex Conditions Face Higher Antibiotic Exposure

Children with complex chronic conditions have a higher likelihood of receiving antibiotic prescriptions than their healthy peers.

Doravirine Add-On Boosts Virologic Control in HIV Infection

Adding doravirine to an existing antiretroviral regimen helps people living with HIV regain virologic control, especially when background drugs remain active.

WHO Says Congo Ebola Outbreak Can Still Be Brought Under Control Within Three Months

A World Health Organization official said on Tuesday it was still possible to bring under control an ⁠Ebola outbreak that is outpacing containment efforts and has become the...

Do TZP-Resistant Bloodstream Infections Raise Death Risk?

Piperacillin-tazobactam resistance does not increase mortality risk in patients with bloodstream infections after accounting for baseline risk factors, a recent study shows.

Data Trends: Pneumococcal Disease Prevention

Pneumococcal disease prevention is evolving fast with updated vaccine recommendations for adults 50+ and exciting next-generation vaccines on the horizon.

Netherlands Reports First West Nile Virus Infection in 6 Years

A West Nile virus infection has ⁠been detected in the Netherlands for the first ⁠time since 2020, Dutch public health institution ⁠RIVM said on ‌Monday.

Ebola Outbreak in Democratic Republic Of Congo Becomes Deadliest in Country's History

The Ebola outbreak in Democratic Republic of Congo has killed 2,325 people, government data showed on Sunday, surpassing the toll from the 2018-2020 outbreak to become the...

Doxycycline Cuts Recurrent Rectal Chlamydia Risk

A shift in prescribing practices at a Seattle sexual health clinic corresponded with a notable decline in recurrent rectal chlamydia cases among men who have sex with men.

Recommended News For You

Q&A: Why adolescents and young adults with cancer are falling behind

"A lot" of aspirin reduces the risk of ovarian cancer, regardless of genetic factors, according to the JAMA study.

Enzalutamide vs Abiraterone: Which is Better for mCSPC?

'It's rare and it's scary.' Dark spot on your fingernail could mean cancer

Breast Cancer Genetic Testing Need in Black Women Identified

Breast Cancer Incidence Rises in Asian American Women

findings from the measurement of disability weights in China with an emphasis on the impact of disease burden.

Recommended Articles For You

Patient Management Following Organ-Preserving Cancer Interventions 

Unlocking the Unknown: A Comprehensive Guide to Stage 4 Vulvar Cancer 

Unlocking the Secret to Accurate ANC Calculation with This Informative Blog Post 

Seeing the Unseen: The Benefits of Early Stage Breast Cancer Ultrasound 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Junk Food & Prostate Cancer; 'Office' Star's Stage IV Diagnosis; New Cancer Cluster?

2.

Inconclusive BRCA Results Linked to Higher BC Risk

3.

TCL1A Protein Identified as Predictor of Blinatumomab Response in Relapsed B-ALL

4.

PSA Testing Is Not Enough for Another Candidate for Prostate Cancer Screening.

5.

Injecting PD-1 Drug Directly Into Oral Precancers Shrinks Lesions

1.

Frontiers in Cancer Therapeutics: U.S. Oncology Trials and Drug Discovery Trends

2.

Critical Care Challenges in Oncologic Emergencies

3.

AI Revolutionizes Immunotherapy: Unveiling Biomarkers with Machine Intelligence

4.

Precision Era in Pediatric Oncology, from Genomic Breakthroughs to Lifelong Learning

5.

Lactic Acid-Linked lncRNAs in Wilms Tumor: Decoding the Tumor Microenvironment & Prognosis

1.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

2.

International Cancer Conference

3.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

From Guidelines to Practice: Hematology

2.

Newer Immunotherapies for Myeloma- A Comprehensive Overview

3.

Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part III

4.

Cost Burden/ Burden of Hospitalization For R/R ALL Patients

5.

Virtual Case Study on Elephantiasis of Lower Limb- An Initiative by Hidoc Dr.

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot